XML 108 R94.htm IDEA: XBRL DOCUMENT v3.24.3
SEGMENT INFORMATION - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue [Line Items]        
Revenues $ 2,510 $ 2,238 $ 7,066 $ 6,349
Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 1,198 999 3,220 2,768
Devices        
Disaggregation of Revenue [Line Items]        
Revenues 567 494 1,626 1,469
OTC        
Disaggregation of Revenue [Line Items]        
Revenues 472 457 1,398 1,313
Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 245 263 746 731
Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 28 25 76 68
Salix        
Disaggregation of Revenue [Line Items]        
Revenues 642 614 1,699 1,667
Salix | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 642 613 1,698 1,668
Salix | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 0 1 1 (1)
International        
Disaggregation of Revenue [Line Items]        
Revenues 291 275 832 781
International | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 63 63 184 178
International | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
International | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 50 47 131 125
International | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 161 151 469 438
International | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 17 14 48 40
Solta Medical        
Disaggregation of Revenue [Line Items]        
Revenues 112 83 302 244
Solta Medical | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 112 83 302 244
Solta Medical | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Diversified        
Disaggregation of Revenue [Line Items]        
Revenues 269 259 722 684
Diversified | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 246 210 637 567
Diversified | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Diversified | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 2 2 5 6
Diversified | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 14 40 65 92
Diversified | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 7 7 15 19
Bausch + Lomb        
Disaggregation of Revenue [Line Items]        
Revenues 1,196 1,007 3,511 2,973
Bausch + Lomb | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 247 113 701 355
Bausch + Lomb | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 455 411 1,324 1,225
Bausch + Lomb | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 420 408 1,262 1,182
Bausch + Lomb | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 70 72 212 201
Bausch + Lomb | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues $ 4 $ 3 $ 12 $ 10